Company Filing History:
Years Active: 2022
Title: Srinivas Ravella: Innovator in Muscarinic Receptor Modulation
Introduction
Srinivas Ravella is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as positive allosteric modulators for muscarinic receptors.
Latest Patents
Srinivas holds a patent for "Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators." This invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, which serve as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The patent details the preparation, pharmaceutical composition, and use of the compound formula (I).
Career Highlights
Srinivas is currently associated with Suven Life Sciences Limited, where he continues to work on innovative solutions in the pharmaceutical sector. His expertise in receptor modulation has positioned him as a key player in the development of new therapeutic agents.
Collaborations
He has collaborated with notable colleagues such as Ramakrishna Nirogi and Abdul Rasheed Mohammed, contributing to a dynamic research environment focused on advancing pharmaceutical science.
Conclusion
Srinivas Ravella's work in the field of muscarinic receptor modulation exemplifies the impact of innovative research on drug development. His contributions are paving the way for new therapeutic options in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.